HIZENTRA for Immunodeficiency common variable: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 76 adverse event reports in the FDA FAERS database where HIZENTRA was used for Immunodeficiency common variable.
Most Reported Side Effects for HIZENTRA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 30 | 15.5% | 0 | 9 |
| Pyrexia | 27 | 14.0% | 0 | 11 |
| Fatigue | 19 | 9.8% | 1 | 6 |
| Infusion site erythema | 18 | 9.3% | 1 | 4 |
| Infusion site swelling | 15 | 7.8% | 0 | 3 |
| Malaise | 15 | 7.8% | 0 | 10 |
| Nausea | 15 | 7.8% | 0 | 6 |
| Vomiting | 13 | 6.7% | 0 | 6 |
| Dyspnoea | 12 | 6.2% | 1 | 4 |
| Pain | 12 | 6.2% | 0 | 5 |
| Sinusitis | 12 | 6.2% | 0 | 4 |
| Bronchitis | 11 | 5.7% | 0 | 7 |
| Chills | 10 | 5.2% | 0 | 4 |
| Meningitis aseptic | 10 | 5.2% | 0 | 5 |
| Chest discomfort | 9 | 4.7% | 0 | 3 |
Other Indications for HIZENTRA
Hypogammaglobulinaemia (23)
Immunodeficiency (8)
Primary immunodeficiency syndrome (8)
Hypoglobulinaemia (6)
Product used for unknown indication (6)
Other Drugs Used for Immunodeficiency common variable
HUMAN IMMUNOGLOBULIN G (17,389)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (1,598)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (881)
GAMMAGARD LIQUID (81)
DUPILUMAB (69)
RITUXIMAB (44)
INFLIXIMAB (28)
PREDNISOLONE (27)
HUMAN C1-ESTERASE INHIBITOR (24)
MYCOPHENOLATE MOFETIL (24)